77
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Effect of patient-specific factors on weekly warfarin dose

, , &
Pages 499-504 | Published online: 28 Dec 2022

References

  • AnsellJHirshJPollerLThe pharmacology and management of the vitamin K antagonistsChest Guidelines2004126204S233S The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines
  • AbsherRKMooreEMParkerMHPatient-specific factors predictive of warfarin dosage requirementsAnn Pharmacother2002361512712243598
  • BlannAHewittJSiddiquiFRacial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0Br J Haematol1999107207910520043
  • CrowtherMAGinsbergJBKearonCA randomized trial comparing 5-mg and 10-mg warfarin loading dosesArch Intern Med19991594689892329
  • DangMNHambletonJKayserSRThe influence of ethnicity on warfarin dosage requirementAnn Pharmacother20053910081215855242
  • EvansMLewisGMIncrease in international normalized ratio after smoking cessation in a patient receiving warfarinPharmacotherapy2005251656165916232028
  • GarciaDReganSCrowtherMWarfarin maintenance dosing patterns in clinical practice: Implications for safer anticoagulation in the elderly populationChest20051372049205615947319
  • GurwitzJHAvornJRoss-DegnanDAging and the anticoagulant response to warfarin therapyAnn Int Med1992116901901580446
  • HarrisonLJohnstonMMassicotteMPComparison of 5-mg and 10-mg loading doses in initiation of warfarin therapyAnn Intern Med199712613369005747
  • HavrdaDEMaiTChonlahanJEnhanced antithrombotic effect of warfarin associated with low-dose alcohol consumptionPharmacotherapy20052530330715767245
  • JamesAHBrittRPRaskinoCLFactors affecting the maintenance dose of warfarinJ Clin Path1992457047061401182
  • MerliGJPrevention of thrombosis with warfarin, aspirin, and mechanical methodsClinical Cornerstone20057495616758652
  • OatesAJacksonPRAustinCAA new regimen for starting warfarin therapy in out-patientsBr J Clin Pharmacol1998461571619723825
  • RiederMJReinerAPGageBFEffect of VKORC1 haplotypes on transcriptional regulation and warfarin doseN Engl J Med200535222859315930419
  • SconceEAKhanTIWynneHAThe impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenBlood20051062329233315947090
  • SinglaDLMorrillGBWarfarin maintenance dosages in the very elderlyAm J Health-Syst Pharm2005621062615901591
  • WittkowskyAKBoccuzziSJWogenJFrequency of concurrent use of warfarin with potentially interacting drugsPharmacotherapy20042416881674